Chemokine receptor genotype and response to interleukin-2 therapy in HIV-1-infected individuals

Interleukin-2 therapy is an immune-based treatment for HIV-1-infected individuals with declining CD4(+) T cell counts. Intravenous IL-2 produces an elevation of circulating CD4(+) T cells, but with a varying degree of effectiveness in individual patients. IL-2 is also known to increase the expressio...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Clinical immunology (Orlando, Fla.). - 1999. - 106(2003), 1 vom: 01. Jan., Seite 36-40
1. Verfasser:	Clegg, Alison (VerfasserIn)
Weitere Verfasser:	Williamson, Peter, Biti, Robyn, Cooper, David, Emery, Sean, Carr, Andrew, Stewart, Graeme
Format:	Aufsatz
Sprache:	English
Veröffentlicht:	2003
Zugriff auf das übergeordnete Werk:	Clinical immunology (Orlando, Fla.)
Schlagworte:	Clinical Trial Journal Article Research Support, Non-U.S. Gov't CCR2 protein, human Interleukin-2 Receptors, CCR2 Receptors, CCR5 Receptors, Chemokine